Pulmonary Tuberculosis II
Pulmonary Tuberculosis III
Acute Pyelonephritis II: Diagnostic Studies and Management
Atypical Pneumonia
Brain Abscess l: Introduction
Appendicitis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 8, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Alberto Diaz de Leon1, Daniel N Costa1, Franto Francis1
1From the Departments of Radiology (A.D.d.L., D.N.C., I.P.), Urology (I.P.), and Pathology (F.F.), and the Advanced Imaging Research Center (D.N.C., I.P.), University of Texas Southwestern Medical Center, 2201 Inwood Rd, 2nd Floor, Suite 202, Dallas, TX 75390-9085.
A 68-year-old man with a history of urothelial carcinoma developed an elevated prostate-specific antigen (PSA) level. Subsequent MRI revealed a prostate lesion, prompting further investigation for potential prostate cancer.
Area of Science:
Background:
Observation:
Findings:
Implications: